Biocidal product authorisations regularly delayed, report finds

摘要

The majority of authorisation applications for biocidal products have been delayed by the member state authorities that are processing them, a monitoring report has found. The report was presented to a meeting of the competent authorities (CAs) for biocides last week. It provides an overview of delays caused to all applications, submitted from 1 January 2010 until 20 August 2020, for: national authorisation; mutual recognition in parallel (MRP); mutual recognition in sequence (MRS);